Is MC a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on M&A recovery and large-cap momentum, with revenue (ttm) at ~$1.55B. The bear case rests on advisory revenue is highly cyclical and tied to the pace of deal closings, so a slowdown in M&A or capital markets can compress results quickly. Analysts covering it are spread from $60.00 to $86.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Advisory revenue is highly cyclical and tied to the pace of deal closings, so a slowdown in M&A or capital markets can compress results quickly. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $60.00, -8.7% from the $65.75 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

M&A recovery and large-cap momentum. Moelis reported strength in large-cap M&A and a double-digit increase in sponsor-related M&A revenue in early 2026. The most optimistic analyst target on MC is $86.00, +30.8% from the $65.75 price. That figure is only reachable if this thesis works close to its best case.

Advisory revenue is highly cyclical and tied to the pace of deal closings, so a slowdown in M&A or capital markets can compress results quickly. Compensation is the largest expense and rising banker pay can squeeze margins even when revenue grows. Geopolitical uncertainty and disruption in private credit markets can delay transactions, and the business depends heavily on retaining a relatively small group of senior rainmakers. Early 2026 results showed record quarterly revenue but adjusted earnings per share came in below analyst expectations, underscoring the sensitivity to costs and timing. The most pessimistic published target is $60.00, -8.7% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Moelis & Company is a global independent investment bank founded in 2007 by Ken Moelis.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (M&A recovery and large-cap momentum) stalling in the reported numbers rather than in the narrative, the risk above (advisory revenue is highly cyclical and tied to the pace of deal closings, so a slowdown in M&A or capital markets can compress results quickly) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

MC is the NYSE ticker for Moelis & Company, a global independent investment bank headquartered in New York. It should not be confused with unrelated foreign-listed companies that use similar symbols.

Moelis advises clients on mergers and acquisitions, restructurings and liability management, private capital raising, and other strategic matters. It earns fees for advice and does not take trading or lending risk on its own balance sheet.

Almost all of Moelis's revenue comes from advisory fees paid when transactions close or milestones are met. Because fees are event-driven, revenue can be lumpy from quarter to quarter and is sensitive to the overall deal environment.